Goldman Sachs’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $828K | Sell |
303,234
-250,171
| -45% | -$683K | ﹤0.01% | 3956 |
|
|
2025
Q1 | $930K | Sell |
553,405
-451,246
| -45% | -$758K | ﹤0.01% | 3852 |
|
|
2024
Q4 | $1.64M | Buy |
1,004,651
+154,653
| +18% | +$252K | ﹤0.01% | 3614 |
|
|
2024
Q3 | $3.54M | Buy |
849,998
+32,662
| +4% | +$136K | ﹤0.01% | 2994 |
|
|
2024
Q2 | $4.46M | Sell |
817,336
-35,440
| -4% | -$194K | ﹤0.01% | 2687 |
|
|
2024
Q1 | $8.53M | Buy |
852,776
+22,484
| +3% | +$225K | ﹤0.01% | 2179 |
|
|
2023
Q4 | $3.39M | Buy |
830,292
+215,650
| +35% | +$880K | ﹤0.01% | 2861 |
|
|
2023
Q3 | $2.38M | Sell |
614,642
-244,607
| -28% | -$947K | ﹤0.01% | 2991 |
|
|
2023
Q2 | $5.12M | Sell |
859,249
-116,845
| -12% | -$696K | ﹤0.01% | 2555 |
|
|
2023
Q1 | $3.19M | Sell |
976,094
-888,404
| -48% | -$2.91M | ﹤0.01% | 2883 |
|
|
2022
Q4 | $7.36M | Buy |
1,864,498
+453,630
| +32% | +$1.79M | ﹤0.01% | 2347 |
|
|
2022
Q3 | $8.47M | Buy |
1,410,868
+559,841
| +66% | +$3.36M | ﹤0.01% | 2251 |
|
|
2022
Q2 | $5.47M | Buy |
851,027
+255,738
| +43% | +$1.64M | ﹤0.01% | 2585 |
|
|
2022
Q1 | $4.92M | Buy |
595,289
+205,796
| +53% | +$1.7M | ﹤0.01% | 2818 |
|
|
2021
Q4 | $6.03M | Buy |
389,493
+116,168
| +43% | +$1.8M | ﹤0.01% | 2653 |
|
|
2021
Q3 | $6.16M | Sell |
273,325
-94,663
| -26% | -$2.13M | ﹤0.01% | 2643 |
|
|
2021
Q2 | $7.24M | Buy |
367,988
+211,202
| +135% | +$4.15M | ﹤0.01% | 2513 |
|
|
2021
Q1 | $5.25M | Buy |
+156,786
| New | +$5.25M | ﹤0.01% | 2630 |
|